X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
37535012514012164
Upgrade
Market Cap Growth
919.37%179.54%-10.81%16.23%87.36%-38.49%
Upgrade
Enterprise Value
19930568577928
Upgrade
Last Close Price
4.124.0022.0125.1629.7968.70
Upgrade
PS Ratio
10.679.9648.93---
Upgrade
PB Ratio
2.011.885.652.751.631.00
Upgrade
P/TBV Ratio
2.352.19-4.162.131.37
Upgrade
EV/Sales Ratio
5.668.6826.73---
Upgrade
Debt / Equity Ratio
0.420.423.531.140.520.62
Upgrade
Net Debt / Equity Ratio
-0.94-0.94-1.08-1.09-1.12-0.65
Upgrade
Net Debt / EBITDA Ratio
2.242.240.170.520.950.56
Upgrade
Net Debt / FCF Ratio
2.052.050.180.581.080.59
Upgrade
Asset Turnover
0.160.160.02---
Upgrade
Inventory Turnover
1.581.58----
Upgrade
Quick Ratio
9.859.853.165.025.505.89
Upgrade
Current Ratio
10.1610.163.415.345.766.27
Upgrade
Return on Equity (ROE)
-75.99%-75.99%-102.26%-161.67%-135.58%-129.28%
Upgrade
Return on Assets (ROA)
-22.86%-22.86%-60.18%-44.38%-40.36%-39.24%
Upgrade
Return on Capital Employed (ROCE)
-30.20%-30.20%-124.50%-86.40%-66.10%-73.00%
Upgrade
Earnings Yield
-21.14%-22.64%-29.93%-72.12%-77.78%-137.70%
Upgrade
FCF Yield
-22.86%-24.48%-104.89%-68.84%-63.97%-111.04%
Upgrade
Buyback Yield / Dilution
-531.04%-531.04%-13.08%-179.91%-146.71%-28.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.